Pricing

Sentynl Therapeutics, Inc.

0 followers

‌

Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.

Industries

Life Sciences, Therapeutics

Headquarters

Solana Beach, US

Employees

11-50

Links

Org chart

Matt Heck

Founder & CEO

Matt Heck

Collapse

Darren Pincus

Senior Vice President, Business Development

Grant Castor

Senior Vice President Commercial Strategy & Operations

Eileen Banaga

Vp, Regulatory Affairs And Quality

Michael Hercz

Senior Vice President, General Counsel & Chief Compliance Officer

Jennifer Reese

Senior Vice President & Head Of Medical Affairs

Mike Cvijanovich

Senior Director Of Rare Disease Marketing

Yvonne Breugelmans Mshrm

Director Of Human Resources And Payroll

Teams

Leadership Team

6 members

Commercial Strategy and Operations

4 members

Regulatory and Compliance

3 members

Similar companies

Grassroots Analytics

54 followers

Vitaquest International LLC

2 followers

University of California, Irvine

15 followers

Ethos Support

14 followers

FirstMark

7 followers

Unite America

1 follower

Engenious Design

2 followers

Shyft Group

3 followers

Priovant

2 followers

Sci.bio Recruiting

6 followers

AlerisLife

1 follower

Explore companies